Skip to main content
logo
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
22.39
-0.45 (-1.97%)
At close: Jan 26, 2026, 4:00 PM EST
22.25
-0.14 (-0.63%)
After-hours: Jan 26, 2026, 7:45 PM EST

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had revenue of $12.77M in the quarter ending September 30, 2025, with 38.54% growth. This brings the company's revenue in the last twelve months to $181.54M, up 1,112.27% year-over-year. In the year 2024, Monte Rosa Therapeutics had annual revenue of $75.62M.

Revenue (ttm)
$181.54M
Revenue Growth
+1,112.27%
P/S Ratio
10.14
Revenue / Employee
$1,354,761
Employees
147
Market Cap
1.77B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202475.62M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ardelyx398.23M
Immunocore Holdings379.59M
Vericel258.72M
Zymeworks134.48M
Syndax Pharmaceuticals111.30M
Nurix Therapeutics83.69M
Celldex Therapeutics2.60M
Revenue Rankings

GLUE News

More News